Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1904)
NICE advice (320)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (797)
Apply filters
Showing 351 to 400 of 1904
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
YAG laser vitreolysis for symptomatic vitreous floaters
IPG741
26 October 2022
26 October 2022
Pembrolizumab for adjuvant treatment of renal cell carcinoma
TA830
19 October 2022
19 October 2022
Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids
TA832
19 October 2022
19 October 2022
Zanubrutinib for treating Waldenstrom's macroglobulinaemia
TA833
19 October 2022
19 October 2022
Fostamatinib for treating refractory chronic immune thrombocytopenia
TA835
19 October 2022
19 October 2022
Osteoarthritis in over 16s: diagnosis and management
NG226
19 October 2022
19 October 2022
SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (terminated appraisal)
TA834
12 October 2022
12 October 2022
Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy
TA827
5 October 2022
5 October 2022
Ozanimod for treating moderately to severely active ulcerative colitis
TA828
5 October 2022
5 October 2022
Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer
MTG72
5 October 2022
5 October 2022
Upadacitinib for treating active ankylosing spondylitis
TA829
30 September 2022
30 September 2022
Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer
TA823
28 September 2022
28 September 2022
Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain
IPG739
22 September 2022
22 September 2022
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis
TA825
21 September 2022
21 September 2022
Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal)
TA826
21 September 2022
21 September 2022
Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia
IPG737
21 September 2022
21 September 2022
Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause
IPG738
21 September 2022
21 September 2022
Neuropad for detecting preclinical diabetic peripheral neuropathy
MTG38
10 September 2018
21 September 2022
Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas
CG118
23 March 2011
20 September 2022
Melphalan for haematological diseases before allogeneic haematopoietic stem cell transplant (terminated appraisal)
TA822
14 September 2022
14 September 2022
Dexamethasone intravitreal implant for treating diabetic macular oedema
TA824
14 September 2022
14 September 2022
Self-harm: assessment, management and preventing recurrence
NG225
7 September 2022
7 September 2022
Brolucizumab for treating diabetic macular oedema
TA820
31 August 2022
31 August 2022
Faecal microbiota transplant for recurrent Clostridioides difficile infection
MTG71
31 August 2022
31 August 2022
iFuse for treating chronic sacroiliac joint pain
MTG39
2 October 2018
30 August 2022
Avalglucosidase alfa for treating Pompe disease
TA821
24 August 2022
24 August 2022
Focal resurfacing implants to treat articular cartilage damage in the knee
IPG734
24 August 2022
24 August 2022
Transcutaneous electrical neuromuscular stimulation for urinary incontinence
IPG735
24 August 2022
24 August 2022
Superficial venous arterialisation for chronic limb threatening ischaemia
IPG736
24 August 2022
24 August 2022
Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies
TA819
17 August 2022
17 August 2022
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma
TA818
17 August 2022
17 August 2022
Cefiderocol for treating severe drug-resistant gram-negative bacterial infections
HTE2
17 August 2022
17 August 2022
Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections
HTE1
17 August 2022
17 August 2022
Type 1 diabetes in adults: diagnosis and management
NG17
26 August 2015
17 August 2022
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
TA815
10 August 2022
10 August 2022
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer
TA816
10 August 2022
10 August 2022
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence
TA817
10 August 2022
10 August 2022
SecurAcath for securing percutaneous catheters
MTG34
5 June 2017
10 August 2022
Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancer
TA812
3 August 2022
3 August 2022
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitors
TA813
3 August 2022
3 August 2022
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis
TA814
3 August 2022
3 August 2022
Bioresorbable stent implantation to treat coronary artery disease
IPG732
3 August 2022
3 August 2022
Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissection
IPG733
3 August 2022
3 August 2022
Duvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal)
TA811
27 July 2022
27 July 2022
PLGF-based testing to help diagnose suspected preterm pre-eclampsia
DG49
27 July 2022
27 July 2022
Transcatheter tricuspid valve annuloplasty for tricuspid regurgitation
IPG730
27 July 2022
27 July 2022
Transcatheter tricuspid valve leaflet repair for tricuspid regurgitation
IPG731
27 July 2022
27 July 2022
Melanoma: assessment and management
NG14
29 July 2015
27 July 2022
Urinary tract infection in under 16s: diagnosis and management
NG224
27 July 2022
27 July 2022
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease
TA809
20 July 2022
20 July 2022
Previous page
1
…
6
7
Current page
8
9
10
…
39
Page
8
of
39
Next page
Results per page
10
25
50
All
Back to top